Among those, RAD21 has been documented as highly expressed in multiple malignant tumors, including colon cancer, endometrial cancer, and prostate cancer, and is shown to promote cancer occurrence and development (Fig. 2B) [14–16]. Here, RAD21 is linked to endometrial cancer.